AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Express News | Pfizer : Citigroup Cuts Target Price to $23 From $27
Pfizer Options Spot-On: On April 10th, 196.86K Contracts Were Traded, With 3.43 Million Open Interest
The Three-year Shareholder Returns and Company Earnings Persist Lower as Pfizer (NYSE:PFE) Stock Falls a Further 8.9% in Past Week
FDA Staff Cuts Are Already Impacting Regulatory Work, Biotech Leaders Warn
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
